Zee Wan Wong
- Oncology top 10%
- COVID-19 and healthcare impacts 5
- Drug Transport and Resistance Mechanisms 4
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 2
-
- Cancer therapeutics and mechanisms 3
-
- Telemedicine and Telehealth Implementation 3
- Health and Medical Research Impacts 2
-
- Patient Satisfaction in Healthcare 2
-
- Health Systems, Economic Evaluations, Quality of Life 2
- Co-authors
- Balram ChowbayPeter AngSuman LalEdmund J.D. LeeEdwin SandanarajNan Soon WongLondon Lucien OoiSrinivasa Rao Jada
- Cited by
- OncologyPharmacologyCancer Research
- Journals
- Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)The British Journal of Psychiatry (1 paper)
- Partner nations
- SingaporeAustraliaUnited States
In The Last Decade
Zee Wan Wong
18 papers receiving 426 citations
Peers
Comparison fields: 5 of 83
- Oncology 251
- Pharmacology 65
- Cancer Research 47
- Pediatrics, Perinatology and Child Health 55
- Cardiology and Cardiovascular Medicine 63
Countries citing papers authored by Zee Wan Wong
This map shows the geographic impact of Zee Wan Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zee Wan Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zee Wan Wong more than expected).
Fields of papers citing papers by Zee Wan Wong
This network shows the impact of papers produced by Zee Wan Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zee Wan Wong. The network helps show where Zee Wan Wong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zee Wan Wong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 23 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 0 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 0 | |
| 9 | Hepatocellular carcinoma: A local registry on risk factors, imaging patterns, treatment strategies and overall survival. | 2021 | 1 |
| 10 | Telehealth in cancer during COVID-19 pandemic | 2020 | 3 |
| 11 | 2020 | 23 | |
| 12 | 2020 | 9 | |
| 13 | 2016 | 20 | |
| 14 | 2015 | 7 | |
| 15 | 2008 | 113 | |
| 16 | 2008 | 57 | |
| 17 | 2008 | 1 | |
| 18 | 2008 | 61 | |
| 19 | 2007 | 73 | |
| 20 | Ethnicity, obstructive sleep apnoea and ischaemic heart disease. | 1999 | 14 |
About Zee Wan Wong
Zee Wan Wong is a scholar working on Oncology, Pharmacology and Public Health, Environmental and Occupational Health, having authored 21 papers that have together received 433 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Cancer therapeutics and mechanisms (3 papers), Telemedicine and Telehealth Implementation (3 papers), Patient Satisfaction in Healthcare (2 papers), Health and Medical Research Impacts (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Oncology (251 citations), Pharmacology (65 citations) and Cancer Research (47 citations). Zee Wan Wong has collaborated with scholars based in Singapore, Australia and United States. Frequent co-authors include Balram Chowbay, Peter Ang, Suman Lal, Edmund J.D. Lee, Edwin Sandanaraj, Nan Soon Wong, London Lucien Ooi, Srinivasa Rao Jada, William D. Figg and Xiaoqiang Xiang. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and The British Journal of Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.